RNA Based Therapeutics Market Size, Share, Growth Report 2030

RNA Based Therapeutics Market: Overview

The report covers a forecast and an analysis of the RNA based therapeutics market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the RNA based therapeutics market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the RNA based therapeutics market on a global and regional level.

In order to give the users of this report a comprehensive view of the RNA based therapeutics market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Request Free Sample

The report provides company market share analysis to give a broader overview of the key players in the RNA based therapeutics market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the RNA based therapeutics market on a global and regional basis.

The study provides a decisive view of the RNA based therapeutics market by segmenting it based on technology, application, end-user, and region. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further classification into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.

Some key players in RNA based therapeutics market include Quark Pharmaceuticals, Alnylam Pharmaceuticals, Dicerna Pharmaceuticals, Tekmira Pharmaceuticals, Benitec Biopharma, Genzyme Corporation, Ionis Pharmaceuticals, Silence Therapeutics, Cenix BioScience, and Sirnaomics.

This report segments the global RNA based therapeutics market into:

Global RNA Based Therapeutics Market: By Technology

• Enabling Technology
  • Microarrays
  • Labeling
  • Purification
  • Linear Amplification
  • qRT-PCR
  • Inhibition
• Enabled Technology
  • RNA Interference (RNAi) Technologies
    • Small Interfering RNA (siRNA)
    • MicroRNA (miRNA)
  • RNA Antisense Technologies

Global RNA Based Therapeutics Market: By Application

• Cardiovascular
• Kidney Diseases
• Oncology
• Infectious Diseases
• Metabolic Disorders
• Others

Global RNA Based Therapeutics Market: By End-User

• Research
• Therapeutics
• Diagnosis
• Others

Global RNA Based Therapeutics Market: By Region

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa